שנת פרסום ראשונה: דצמבר 2013
שנת עדכון:
מפרסם: Pediatric Clinics of North America


  • The thalassemia syndromes are a heterogeneous group of disorders characterized by variable degrees of hemolysis, chronic anemia, and ineffective erythropoiesis.
  • Because more patients are living longer, disease- and treatment-related complications are becoming more common.
  • Optimal and safe transfusion support, iron chelation, noninvasive iron assessments, and stem cell therapies provide new tools for effective management of thalassemia.

Pediatr Clin N Am 60 (2013) 1383–1391